Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Cash from Financing Activities: 2012-2024

Historic Cash from Financing Activities for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to -$81.0 million.

  • Amphastar Pharmaceuticals' Cash from Financing Activities rose 80.95% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.9 million, marking a year-over-year increase of 12.00%. This contributed to the annual value of -$81.0 million for FY2024, which is 117.83% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Cash from Financing Activities is -$81.0 million, which was down 117.83% from $454.1 million recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Cash from Financing Activities ranged from a high of $454.1 million in FY2023 and a low of -$81.0 million during FY2024.
  • Its 3-year average for Cash from Financing Activities is $115.6 million, with a median of -$26.4 million in 2022.
  • In the last 5 years, Amphastar Pharmaceuticals' Cash from Financing Activities plummeted by 1,548.17% in 2021 and then spiked by 1,817.51% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Cash from Financing Activities (Yearly) stood at -$2.2 million in 2020, then slumped by 1,548.17% to -$37.0 million in 2021, then rose by 28.58% to -$26.4 million in 2022, then surged by 1,817.51% to $454.1 million in 2023, then tumbled by 117.83% to -$81.0 million in 2024.